Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03580135
Collaborator
(none)
28
1
2
11
2.6

Study Details

Study Description

Brief Summary

The study will be self-funded by investigator and carried out on patients from outpatient clinic in Pediatric Dentistry and Public Health Department- Faculty of Dentistry, Cairo University- Egypt. The procedures will be carried out by postgraduate student Rawda Nader Fathy who has B.D.S. (2011) -Alexandria University- Egypt. The procedures will be carried out on a Knight Midmark Biltmore dental unit (Midmark Corporation 1700 S. Patterson Blvd. Suite 400 Dayton, Ohio 45409, USA) in the post graduate clinic of Pediatric Dentistry and Public Health Department- Faculty of Dentistry, Cairo University- Egypt.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars: A Randomized Controlled Trial
Actual Study Start Date :
Nov 1, 2018
Actual Primary Completion Date :
Jan 2, 2019
Anticipated Study Completion Date :
Oct 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Propolis powder

resin (50%), vegetable Balsam, wax essential aromatic oils (30%) salivary secretions (10%) pollen(5%) other substances (5%) including amino acids ,ethanol vitamin A, B complex, and E, minerals, steroids flavonoids. The most important pharmacologically active constituents in propolis are flavonoids, which are well-known compounds which have antioxidant, anti-bacterial, antifungal, antiviral, and anti-inflammatory properties. Other ingredients: carob powder (free flow agent). Contains no yeast, salt, sugar, starch, milk, preservatives or colors.

Drug: Propolis
One and half gram of Standardized Propolis Extract powder (Y.S. Eco Bee Farms Propolis Powder) at 100% was mixed with 1.75 mL of polyethylene glycol (Continental Chemicals, New Delhi, India) to form a thick consistency on a clean dry glass slab with a metal spatula. The paste was carried to the pulp stumps with a metal carrier and then condensed lightly to a thickness of 2 - 3 mm followed by placement of thick mix of GIC to seal the cavity and covered by st.st crown.
Other Names:
  • propolis bee resin
  • Active Comparator: Mineral Tri Oxide

    Consists of calcium oxide and silicon dioxide.When these raw materials are blended, they produce tricalcium silicate, dicalcium silicate, tricalcium aluminate, and tetracalcium aluminoferrite. A radiopacifier (bismuth oxide) is added to the cement for dental radiological diagnosis.

    Drug: Mineral Trioxide Aggregate
    MTA paste will be prepared as per the manufacturers' instructions to obtain a putty-like consistency. The mixture will be delivered to the pulp stumps and condensed lightly with a moistened sterile cotton pellet to ensure a thickness of 2 to 3 mm. A thick mix of glass ionomer cement (GIC) will applied over the MTA and covered by st.st crown.
    Other Names:
  • MTA
  • Outcome Measures

    Primary Outcome Measures

    1. Evaluation of postoperative pain after pulpotomy by asking patient and/or parents (binary yes or no) [9 months]

      Binary (yes or no)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 8 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Cooperative patient

    2. Healthy 5-8 years old patient with at least one carious primary molar tooth at each side of the patient's mouth.

    3. Presence of at least two-thirds of the root length radiographically.

    4. Restorable tooth.

    5. No signs of hyperemia and hemostasis will be adequately achieved with moistened cotton pellet within 5 minutes after coronal pulp amputation.

    Exclusion Criteria:
    1. Teeth showing clinical and radiographic evidence of pulp degeneration such as history of spontaneous or nocturnal pain, tenderness to percussion or palpation, pathologic mobility, swelling or fistulous tract, periodontal ligament (PDL) space widening, internal root resorption, external root resorption, furcal radiolucency/inter- radicular bone destruction and/or periapical bone destruction.

    2. Patients eliciting history of known allergy to pollens associated with propolis.

    3. Parent or guardian refusal to participate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cairo University Cairo Egypt

    Sponsors and Collaborators

    • Cairo University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Rawda Nader Mahmoud, Principal Investigator, Cairo University
    ClinicalTrials.gov Identifier:
    NCT03580135
    Other Study ID Numbers:
    • Rawda N.Mahmoud
    First Posted:
    Jul 9, 2018
    Last Update Posted:
    Jul 29, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Rawda Nader Mahmoud, Principal Investigator, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 29, 2019